Inhibition of concanavalin A-induced mice hepatitis by coumarin derivatives

被引:46
|
作者
Okamoto, T
Yoshida, S
Kobayashi, T
Okabe, S
机构
[1] Nippon Chemiphar Co Ltd, Res Labs, Misato, Saitama 3410005, Japan
[2] Kyoto Pharmaceut Univ, Dept Appl Pharmacol, Kyoto 6078414, Japan
关键词
coumarin; concanavalin A; liver;
D O I
10.1254/jjp.85.95
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of coumarin derivatives, osthole, imperatorin, Pd-Ia, Pd-II and Pd-III, on mice concanavalin A (Con A) (0.2 mg/mouse, i.v.)-induced hepatitis were studied. At the dose of 200 mg/kg (i.p.), these coumarins inhibited more than 90% of the Con A-induced elevation of plasma alanine aminotransferase activity, but glycyrrhizin (200 mg/kg, i.p.) caused only 45% inhibition. At the dose of 100 mg/kg (i.p.), osthole produced the strongest inhibition among these coumarins. The inhibitory activity of osthole is lost when its 7-methoxy group is replaced by a 7-hydroxy group to form osthenol. The present results showed that coumarin derivatives inhibited Con A-induced hepatitis, with osthole being the most inhibitory.
引用
收藏
页码:95 / 97
页数:3
相关论文
共 50 条
  • [31] A microarray analysis of early activated pathways in concanavalin A-induced hepatitis
    Qing-yi Cao
    Feng Chen
    Jie Li
    Shan-shan Wu
    Jing Wang
    Zhi Chen
    Journal of Zhejiang University SCIENCE B, 2010, 11 : 366 - 377
  • [32] Hydrogen from intestinal bacteria is protective for Concanavalin A-induced hepatitis
    Kajiya, Mikihito
    Sato, Kimihiro
    Silva, Marcelo J. B.
    Ouhara, Kazuhisa
    Do, Phi M.
    Shanmugam, K. T.
    Kawai, Toshihisa
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 386 (02) : 316 - 321
  • [33] A microarray analysis of early activated pathways in concanavalin A-induced hepatitis
    Cao, Qing-yi
    Chen, Feng
    Li, Jie
    Wu, Shan-shan
    Wang, Jing
    Chen, Zhi
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2010, 11 (05): : 366 - 377
  • [35] Suppressive role of hepatic dendritic cells in concanavalin A-induced hepatitis
    Tomiyama, C.
    Watanabe, H.
    Izutsu, Y.
    Watanabe, M.
    Abo, T.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 166 (02) : 258 - 268
  • [36] Protective role of synthetic oligodeoxynucleotides expressing immunosuppressive TTAGGG motifs in concanavalin A-induced hepatitis
    Li, Ning
    Liu, Yue-Hui
    Li, Sha-Ling
    Fu, Chun-Yan
    Zhou, Rong-Rong
    Huang, Yan
    Fan, Xue-Gong
    IMMUNOLOGY LETTERS, 2013, 151 (1-2) : 54 - 60
  • [37] NC-1500 prevents concanavalin A-induced mice hepatitis without affecting cytokine gene expression
    Okamoto, T
    Kobayashi, T
    Jeong, SY
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2001, 8 (02) : 181 - 182
  • [38] Protective effects of hesperidin on concanavalin A-induced hepatic injury in mice
    Li, Gang
    Chen, Mao-jian
    Wang, Chao
    Nie, Hao
    Huang, Wen-jian
    Yuan, Ting-dong
    Sun, Ting
    Shu, Ke-gang
    Wang, Chang-fu
    Gong, Quan
    Tang, Shao-qian
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 21 (02) : 406 - 411
  • [39] Roles of platelets and macrophages in the protective effects of lipopolysaccharide against concanavalin A-induced murine hepatitis
    Yu, Zhiqian
    Otsuka, Hirotada
    Yamaguchi, Kouji
    Kuroishi, Toshinobu
    Sasano, Takashi
    Sugawara, Shunji
    Nakamura, Masanori
    Endo, Yasuo
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (09): : 1069 - 1079
  • [40] Therapeutic administration of Y-40138, a multiple cytokine modulator, inhibits concanavalin A-induced hepatitis in mice
    Fukuda, T
    Mogami, A
    Hisadome, M
    Komatsu, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 523 (1-3) : 137 - 142